Breast cancer risks in individuals testing negative for a known family mutation in BRCA1 or BRCA2.
Breast Cancer Research and Treatment.
Times cited: 38
Evaluation of a candidate breast cancer associated SNP in ERCC4 as a risk modifier in BRCA1 and BRCA2 mutation carriers. Results from the consortium of investigators of modifiers of BRCA1/BRCA2 (CIMBA).
British Journal of Cancer.
Times cited: 12
The APC I1307K allele and breast cancer risk.
Times cited: 44